Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:39 PM
Ignite Modification Date:
2025-12-24 @ 4:39 PM
NCT ID:
NCT02962466
Eligibility Criteria:
Inclusion Criteria:
* scheduled for intracytoplasmatic sperm injection (ICSI) and single embryo transfer on day 3
* patients down regulated with gonadotropin-releasing hormone (GnRH) antagonist and stimulated with Highly Purified human Menopausal Gonadotropin (HP-hMG)
* no more than 2 previous IVF or ICSI cycles with transfer prior to this one.
* Body mass index (BMI) should be higher than 17 and lower than 32
* patients should have regular menstrual cycles (between 24 and 35 days).
Exclusion Criteria:
* are smokers (\>10 cigarettes per day)
* patients requesting Prenatal Genetic Diagnosis
* patients having polycystic ovary syndrome (PCOS), or Severe Endometriosis (AFS Stage 3-4)
* couples where the partner has an extremely low sperm count e.g.: extreme oligo-astheno-teratozoospermia (OAT), (\<100.000/ml) or testicular sperm extraction (TESE)
* results of eventual preceding cycles may not indicate a known genetic disease, or low ovarian response or an oocyte maturation defect.
Healthy Volunteers:
False
Sex:
FEMALE
Maximum Age:
40 Years
Study:
NCT02962466
Study Brief:
Protocol Section:
NCT02962466